ERBB2 and neoplasm: Based on the expression of hormone receptors and human epidermal growth factor receptor (HER)-2, major tumor categories can be defined to guide the selection of hormonal therapy (tumors expressing hormone receptors), drugs targeting HER-2 (HER-2 overexpressing tumors), or cytotoxic chemotherapy (triple negative tumors) as the principal modalities of systemic treatment.